Literature DB >> 32550978

Therapeutic Potential of Targeted Nanoparticles and Perspective on Nanotherapies.

Vanna Sanna1, Mario Sechi2.   

Abstract

Engineered nanoparticles (NPs) to specifically deliver payload therapeutics to target cells involved in pathophysiological processes seem to offer a powerful strategy to overcome intrinsic limitations of drugs. In this Viewpoint we disclose the synergistic potential between medicinal chemistry and nanomedicine to exploit the "targeting concept" in developing effective nanotherapeutics, as well as the challenges and limitations that should be considered in pursuing their clinical translation, especially toward precision medicine.
Copyright © 2020 American Chemical Society.

Year:  2020        PMID: 32550978      PMCID: PMC7294587          DOI: 10.1021/acsmedchemlett.0c00075

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  20 in total

Review 1.  Survey of Clinical Translation of Cancer Nanomedicines-Lessons Learned from Successes and Failures.

Authors:  Hongliang He; Lisha Liu; Emily E Morin; Min Liu; Anna Schwendeman
Journal:  Acc Chem Res       Date:  2019-08-19       Impact factor: 22.384

Review 2.  Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation.

Authors:  Jinjun Shi; Zeyu Xiao; Nazila Kamaly; Omid C Farokhzad
Journal:  Acc Chem Res       Date:  2011-06-21       Impact factor: 22.384

Review 3.  Clinical Translation of Nanomedicine.

Authors:  Yuanzeng Min; Joseph M Caster; Michael J Eblan; Andrew Z Wang
Journal:  Chem Rev       Date:  2015-06-19       Impact factor: 60.622

Review 4.  Tumor targeting via EPR: Strategies to enhance patient responses.

Authors:  Susanne K Golombek; Jan-Niklas May; Benjamin Theek; Lia Appold; Natascha Drude; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2018-07-19       Impact factor: 15.470

5.  A Status Report on FDA Approval of Medical Devices Containing Nanostructured Materials.

Authors:  A-Andrew D Jones; Gujie Mi; Thomas J Webster
Journal:  Trends Biotechnol       Date:  2018-07-31       Impact factor: 19.536

6.  Smart cancer nanomedicine.

Authors:  Roy van der Meel; Einar Sulheim; Yang Shi; Fabian Kiessling; Willem J M Mulder; Twan Lammers
Journal:  Nat Nanotechnol       Date:  2019-11-06       Impact factor: 39.213

7.  New Chemical Modalities and Strategic Thinking in Early Drug Discovery.

Authors:  Maria-Jesus Blanco; Kevin M Gardinier
Journal:  ACS Med Chem Lett       Date:  2020-01-14       Impact factor: 4.345

8.  Precision Cancer Nanotherapy: Evolving Role of Multifunctional Nanoparticles for Cancer Active Targeting.

Authors:  Anas Ahmad; Farheen Khan; Rakesh Kumar Mishra; Rehan Khan
Journal:  J Med Chem       Date:  2019-08-01       Impact factor: 7.446

Review 9.  Influence of tumour micro-environment heterogeneity on therapeutic response.

Authors:  Melissa R Junttila; Frederic J de Sauvage
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

Review 10.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

View more
  10 in total

Review 1.  A decennary update on applications of metal nanoparticles (MNPs) in the synthesis of nitrogen- and oxygen-containing heterocyclic scaffolds.

Authors:  Tejas M Dhameliya; Hiren A Donga; Punit V Vaghela; Bhoomi G Panchal; Dipen K Sureja; Kunjan B Bodiwala; Mahesh T Chhabria
Journal:  RSC Adv       Date:  2020-09-03       Impact factor: 4.036

Review 2.  Synthetic high-density lipoprotein nanoparticles: Good things in small packages.

Authors:  Robert M Lavker; Nihal Kaplan; Kaylin M McMahon; Andrea E Calvert; Stephen E Henrich; Ummiye V Onay; Kurt Q Lu; Han Peng; C Shad Thaxton
Journal:  Ocul Surf       Date:  2021-04-21       Impact factor: 6.268

3.  Transient Vasodilation in Mouse 4T1 Tumors after Intragastric and Intravenous Administration of Gold Nanoparticles.

Authors:  Kamil Brzoska; Małgorzata Szczygiel; Agnieszka Drzał; Martyna Sniegocka; Dominika Michalczyk-Wetula; Eva Biela; Martyna Elas; Lucyna Kapka-Skrzypczak; Hanna Lewandowska-Siwkiewicz; Krystyna Urbańska; Marcin Kruszewski
Journal:  Int J Mol Sci       Date:  2021-02-26       Impact factor: 5.923

Review 4.  Stem Cell Mimicking Nanoencapsulation for Targeting Arthritis.

Authors:  Min Jun Shin; Jun Young Park; Dae Ho Lee; Dongwoo Khang
Journal:  Int J Nanomedicine       Date:  2021-12-31

5.  Poly(amidoamine) Dendrimers as Nanocarriers for 5-Fluorouracil: Effectiveness of Complex Formation and Cytotoxicity Studies.

Authors:  Magdalena Szota; Katarzyna Reczyńska-Kolman; Elżbieta Pamuła; Olga Michel; Julita Kulbacka; Barbara Jachimska
Journal:  Int J Mol Sci       Date:  2021-10-16       Impact factor: 5.923

Review 6.  Combining Nanotechnology and Gas Plasma as an Emerging Platform for Cancer Therapy: Mechanism and Therapeutic Implication.

Authors:  Milad Rasouli; Nadia Fallah; Sander Bekeschus
Journal:  Oxid Med Cell Longev       Date:  2021-10-27       Impact factor: 6.543

Review 7.  Extracellular vesicles as a novel photosensitive drug delivery system for enhanced photodynamic therapy.

Authors:  Lingjun Tong; Sitong Zhang; Rong Huang; Huaxi Yi; Jiong-Wei Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-09-27

Review 8.  Recent progress in micro and nano-encapsulation of bioactive derivatives of the Brazilian genus Pterodon.

Authors:  Janaina de Alcantara Lemos; Anna Eliza M F M Oliveira; Raquel Silva Araujo; Danyelle M Townsend; Lucas Antonio Miranda Ferreira; Andre Luis Branco de Barros
Journal:  Biomed Pharmacother       Date:  2021-09-07       Impact factor: 6.529

9.  Ex vivo Live Cell Imaging of Nanoparticle-Cell Interactions in the Mouse Lung.

Authors:  Fernanda Ramos-Gomes; Nathalia Ferreira; Alexander Kraupner; Frauke Alves; M Andrea Markus
Journal:  Front Bioeng Biotechnol       Date:  2020-10-30

10.  Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition.

Authors:  Vanna Sanna; Sandro Satta; Tzung Hsiai; Mario Sechi
Journal:  Eur J Med Chem       Date:  2022-01-13       Impact factor: 6.514

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.